Details for New Drug Application (NDA): 010355
✉ Email this page to a colleague
The generic ingredient in QUARZAN is clidinium bromide. There are seven drug master file entries for this compound. Additional details are available on the clidinium bromide profile page.
Summary for 010355
Tradename: | QUARZAN |
Applicant: | Roche |
Ingredient: | clidinium bromide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 2.5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription